Press Releases
LI-COR Biotechnology Featured in the Global Health Series
27 July 2023 -- Nebraska, US -- LI-COR Biotechnology, a world leader in imaging solutions for biomolecular analysis, is proud to announce it will be featured as part of the Global Health campaign, which aims to promote innovation and development in healthcare worldwide. The Global Health campaign has been launched to coincide with the Global Health Summit 2023 in Geneva, Switzerland.
“We are very proud to be part of the Global Health campaign whose mission is to highlight major innovations impacting healthcare around the world,” said Katie Schaepe, senior product manager at LI-COR Biotechnology.
LI-COR Biotechnology develops state-of-the-art optical imaging solutions that are integrated with dedicated reagents, software and support to enable life science professionals to advance their knowledge on human biology.
“Our solutions empower researchers to unlock their next discovery with speed, accuracy and consistency; advancing their studies of accurate diagnostic tests and effective therapeutics needed to treat and cure common and rare human diseases,” said Dr Michael Furtaw, director of R&D at LI-COR Biotechnology.
Throughout LI-COR's 50 years of innovation, the company has endeavoured to be at the forefront of technological development and continues to diversify by developing the cutting-edge products needed by researchers in today’s scientific world.
“We are committed to improving the human condition and we believe that by enabling life science researchers to understand human physiology and the nature of disease more effectively is one of the most impactful ways in which our organisation can contribute to the improvement of human health worldwide," said Bambi Reynolds, VP and general manager at LI-COR Biotechnology.
About LI-COR Biotechnology
LI-COR technology enables scientists around the world to improve lives by advancing discovery. From the first low-cost light sensor filtered for the waveband absorbed by plants, to pioneering the development of near-infrared fluorescence detection systems for DNA sequencing, LI-COR strives to provide innovative solutions for researchers.
Today, LI-COR Biosciences is a leading innovator in systems for plant research, gas analysis, drug discovery, protein research, and small animal imaging. Visit: www.licor.com.
27 July 2023 -- Nebraska, US -- LI-COR Biotechnology, a world leader in imaging solutions for biomolecular analysis, is proud to announce it will be featured as part of the Global Health campaign, which aims to promote innovation and development in healthcare worldwide. The Global Health campaign has been launched to coincide with the Global Health Summit 2023 in Geneva, Switzerland.
“We are very proud to be part of the Global Health campaign whose mission is to highlight major innovations impacting healthcare around the world,” said Katie Schaepe, senior product manager at LI-COR Biotechnology.
LI-COR Biotechnology develops state-of-the-art optical imaging solutions that are integrated with dedicated reagents, software and support to enable life science professionals to advance their knowledge on human biology.
“Our solutions empower researchers to unlock their next discovery with speed, accuracy and consistency; advancing their studies of accurate diagnostic tests and effective therapeutics needed to treat and cure common and rare human diseases,” said Dr Michael Furtaw, director of R&D at LI-COR Biotechnology.
Throughout LI-COR's 50 years of innovation, the company has endeavoured to be at the forefront of technological development and continues to diversify by developing the cutting-edge products needed by researchers in today’s scientific world.
“We are committed to improving the human condition and we believe that by enabling life science researchers to understand human physiology and the nature of disease more effectively is one of the most impactful ways in which our organisation can contribute to the improvement of human health worldwide," said Bambi Reynolds, VP and general manager at LI-COR Biotechnology.
About LI-COR Biotechnology
LI-COR technology enables scientists around the world to improve lives by advancing discovery. From the first low-cost light sensor filtered for the waveband absorbed by plants, to pioneering the development of near-infrared fluorescence detection systems for DNA sequencing, LI-COR strives to provide innovative solutions for researchers.
Today, LI-COR Biosciences is a leading innovator in systems for plant research, gas analysis, drug discovery, protein research, and small animal imaging. Visit: www.licor.com.
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.